MEDTRONIC CRYOCATH LP

데이터베이스에서 발견된 의료기기 1건 데이터베이스에서 발견된 의료기기 7 건

  • 모델명 / 제조번호(시리얼번호)
    Model Catalog: 3FC12 (Lot serial: 2399); Model Catalog: 3FC12 (Lot serial: 2308); Model Catalog: 3FC12 (Lot serial: 2442); Model Catalog: 3FC12 (Lot serial: 2443); Model Catalog: 3FC12 (Lot serial: 2444); Model Catalog: 3FC12 (Lot serial: 1919); Model Catalog: 3FC12 (Lot serial: 1920); Model Catalog: 3FC12 (Lot serial: 2288); Model Catalog: 3FC12 (Lot serial: 2309); Model Catalog: 3FC12 (Lot serial: 2391); Model Catalog: 3FC12 (Lot serial: 2390); Model Catalog: 3FC12 (Lot serial: 2389); Model Catalog: 3FC12 (Lot serial: 2364); Model Catalog: 3FC12 (Lot serial: 2363); Model Catalog: 3FC12 (Lot serial: 2348); Model Catalog: 3FC12 (Lot serial: 2340); Model Catalog: 3FC12 (Lot serial: 2400)
  • 제품 설명
    flexcath steerable sheath 3FC12
  • 모델명 / 제조번호(시리얼번호)
    Model Catalog: FREEZOR 5 207F5 (Lot serial: ALL LOTS); Model Catalog: FREEZOR 3 207F3 (Lot serial: ALL LOTS); Model Catalog: FREEZOR 1 207F1 (Lot serial: ALL LOTS)
  • 제품 설명
    FREEZOR CARDIAC CRYOABLATION CATHETERS
  • 모델명 / 제조번호(시리얼번호)
    Model Catalog: 3FC12 (Lot serial: >10 numbers contact mfg)
  • 제품 설명
    FLEXCATH STEERABLE SHEATH Model 3FC12
  • 모델명 / 제조번호(시리얼번호)
    Model Catalog: 2FC12 (Lot serial: 01068); Model Catalog: 2FC12 (Lot serial: 00036); Model Catalog: 2FC12 (Lot serial: 00070); Model Catalog: 2FC12 (Lot serial: 00085); Model Catalog: 2FC12 (Lot serial: 00170); Model Catalog: 2FC12 (Lot serial: 00277); Model Catalog: 2FC12 (Lot serial: 00344); Model Catalog: 2FC12 (Lot serial: 00363); Model Catalog: 2FC12 (Lot serial: 00400); Model Catalog: 2FC12 (Lot serial: 00431); Model Catalog: 2FC12 (Lot serial: 50811); Model Catalog: 2FC12 (Lot serial: 50711); Model Catalog: 2FC12 (Lot serial: 50614); Model Catalog: 2FC12 (Lot serial: 50419); Model Catalog: 2FC12 (Lot serial: 50111); Model Catalog: 2FC12 (Lot serial: 01186); Model Catalog: 2FC12 (Lot serial: 01185); Model Catalog: 2FC12 (Lot serial: 01153); Model Catalog: 2FC12 (Lot serial: 01105); Model Catalog: 2FC12 (Lot serial: 01099); Model Catalog: 2FC12 (Lot serial: 00017); Model Catalog: 2FC12 (Lot serial: 01010); Model Catalog: 2FC12 (Lot serial: 01009); Model Catalog: 2FC12 (Lot serial: 00861); Model Catalog:
  • 제품 설명
    FLEXCATH STEERABLE SHEATH
  • 모델명 / 제조번호(시리얼번호)
    Model Catalog: (Lot serial: 207FI 207F3 207F5); Model Catalog: (Lot serial: 21201)
  • 제품 설명
    F7 FREEZOR CARDIAC CRYOABLATION CATH
하나 더 2 건 더

유사한 이름을 가진 의료기기 1건 유사한 이름을 가진 의료기기 10 건

데이터에 대해 더 자세히 알아보기 여기

  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NZMMDSA
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    MSHM
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    AEMPSVFOI
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    BAM
  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    MHSIDCCCDMIS
하나 더 5 건 더